Protein‐truncating variants in three DNA damage repair genes (PALB2, BRCA2, and ATM) were associated with a significant risk of pancreatic cancer (p < 0.05), with odds ratio ranging from 5.03 to 10.03 (Figure 3C and Table S3). This evidence concerns the gene PALB2 and familial pancreatic carcinoma.